Open AccessRecurrent chronic myeloid leukemia with t (9;22;16) (q34; q11; p13) treated by nilotinib
Author(s) -
Yefei Shu,
Wei Yang,
Xuejin Zhang,
Xiaofeng Xu
Publication year - 2018
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000012875
Subject(s) - nilotinib , medicine , chromosomal translocation , dasatinib , myeloid leukemia , philadelphia chromosome , imatinib , tyrosine kinase inhibitor , tyrosine kinase , gastroenterology , imatinib mesylate , cancer research , genetics , biology , cancer , gene , receptor